Yet, no significant difference was noticed in the percentage of BTLA+ cells on CD8+ T cells between PBMC and tumor tissues (87.23 ± 1.665% vs. 86.98 ± 3.576%, p = 0.9464; Figure 4B). This evidence concerns the gene BTLA and neoplasm.